In addition, lower-level infiltrations of other types of immune cells are often observed in patients with KEAP1-mutated LUAD in the Cancer Genome Atlas (TCGA) database,28 the Tumor Immune Estimation Resource (TIMER) database,29 and the randomized phase III IMpower131 study.30 The gene discussed is KEAP1; the disease is cancer.